Abstract:Objective: The primary objective of this study was to determine the frequency and nature of complications that occur during intrathecal baclofen (ITB) therapy, including nonsurgical complications as well as complications associated with both implantation surgeries and subsequent revisions. Methods: The authors retrospectively reviewed the medical records of all patients who had baclofen pumps implanted at a tertiary children's hospital from 2006 through June 2019. The study employed appropriate descriptive statistics and statistical models to analyze patient demographics, improvements in tone, and clinical complications. The authors evaluated the associations of complications as well as changes in modified Ashworth Scale (MAS) scores with various preexisting conditions (e.g., presence of gastrostomy tubes [G-tubes] and ventriculoperitoneal [VP] shunts) and surgical variations (e.g., use of newer [Ascenda] catheters and subfascial versus subcutaneous catheter tunneling). Results: One hundred forty-two pumps were implanted. Complications occurred in 111 patients (78.2%). The most frequent complications were catheter complications and pseudomeningoceles, each of which occurred in 63 (44%) patients. On multivariable analysis, pseudomeningoceles and percutaneous CSF leaks were significantly less likely when intrathecal catheters were placed via laminotomy versus spinal needle (OR 4.6, p = 0.044), and when catheters were passed from the posterior incision to the abdominal pump pocket deep to the thoracolumbar fascia rather than superficial to it (OR 2.7, p = 0.008). Preexisting G-tubes and VP shunts at the time of pump implantation were not associated with a significantly increased likelihood of pump malfunction or infection. Ascenda catheters were significantly less likely to have disconnections (p < 0.001) and obstructions (p = 0.016), and overall were less likely to have any catheter-related complications (p = 0.01). Patients with preexisting VP shunts at the time of implantation had a significantly greater mean decrease in MAS scores in both their lower extremities (1.8, p = 0.003) and upper extremities (1.3, p = 0.002) than did patients without shunts. Conclusions: Various complications are associated with ITB therapy, most commonly catheter complications and pseudomeningoceles. There have been fewer catheter complications associated with the newest catheter model, while pseudomeningoceles have become less frequent since the surgical technique was modified to prevent them. VP shunts and G-tubes are not associated with significantly higher complication rates and shunts seem to be associated with greater efficacy of ITB therapy, as represented by a greater mean improvement in MAS scores.

Interaction between a smartphone and intrathecal baclofen pump case report

An unusual intrathecal baclofen pump failure thirteen months after implantation

Management of high-dose intrathecal baclofen pump explant: A case report

Complications of intrathecal baclofen therapy in children and young adults

Infectious Complications and Operative Management of Intrathecal Baclofen Pumps in the Pediatric Population: A Systematic Review and Meta-Analysis of 20 Years of Pooled Experience

The presence of Candida parapsilosis with intrathecal baclofen pump in a person with high cervical spinal cord injury; infection or colonization? A Case Report

Peritoneal baclofen pump migration: a rare complication of subfascial placement. Illustrative cases

Intrathecal Baclofen to Improve Functional Status in ALS: A Case Report

Case report: Intrathecal baclofen therapy improved gait pattern in a stroke patient with spastic dystonia

Intrathecal baclofen therapy for spasticity in a person with spinal cord injury and end-stage renal disease dependent on hemodialysis: a case report

PHYSIOTHERAPEUTIC POTENTIAL BEFORE AND AFTER IMPLANTATION OF INTRATHECAL BACLOFEN INFUSION PUMP FOR TREATING SPASTICITY IN CHILD WITH CEREBRAL PALSY

Safety and efficacy of intrathecal baclofen trials for the treatment of hypertonia: a retrospective cohort study

Spinal catheter revision in pediatric intrathecal baclofen pumps: risk factors and postoperative outcomes

Prolonged administration of intrathecal baclofen in a patient with generalized grade 4 tetanus

Three consecutive pregnancies in a woman with spastic cerebral palsy being treated with intrathecal baclofen therapy

Effectiveness, Safety, and Feasibility

Intrathecal Baclofen Pump Infection With Meningitis: Effective Treatment by Radical Debridement and Intrareservoir Baclofen–Vancomycin Co-Infusion

Intrathecal baclofen obviating the need for bladder stimulator use in a patient with secondary dystonia: illustrative case

Sexual Dysfunction Induced by Intrathecal Baclofen Administration: Is This the Price to Pay for Severe Spasticity Management?

[Intrathecal baclofen therapy: a 30-year experience]

Potentially Life-Threatening Interaction between Opioids and Intrathecal Baclofen in Individuals with a Childhood-Onset Neurological Disorder: A Case Series and Review of the Literature